Identification
Instrument name
PIXIUM VISION
Symbol
ALPIX
ISIN code
FR0011950641
LEI code
96950046OPLRLKKEOO08
Exchange / Market
Euronext Growth
Trading location
Paris
ICB
Medical Equipment
Website address
Operation
IPO date
Issue type
Transfer
Transfer
Euronext - Euronext Growth

Company profile

Pixium Vision specializes in developing electronic retinal implants. Products are for people having lost their sight due to degenerative eye disorders such as retinitis pigmentosa.

Source: Cofisem - Last Update: 19 Feb 2020
Key Executives
Chief Executive Officer Lloyd Diamond
Administrative & Finance Director Didier Laurens
Source: Cofisem - Last Update: 14 Feb 2020
Key figures
Millenium 2019 2018 2017 2016 2015
Net sales 100
Income from ordinary activities 1.718 1.323 2.157
Operating income -8.870 -12.294 -12.666 -15.015 -15.697
Cost (net) of financial indebtedness -883 -921 -749
Equity-accounted companies' contribution to results
Net profit from discontinued activities
Net income -9.876 -13.571 -13.542 -12.441 -15.644
Net income (Group share) -9.876 -13.571 -13.542 -12.441 -15.644
Fiscal year end 12,19 12,18 12,17 12,16 12,15
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit EUR - thousands EUR - thousands EUR - thousands EUR - thousands EUR - thousands
Account Standards
Source: Cofisem - Last Update: 19 Feb 2020
Shareholder information
Flottant 42,24 %
Sofinnova Partners 13,75 %
Bpifrance 12,09 %
Abingworth Holdings Sarl 7,11 %
Employees 5,97 %
Managers 5,51 %
Omnes Capital 4,89 %
Kreos Capital 4,45 %
Autres fondateurs 2,29 %
Group-owned stock 0,14 %
Source: Cofisem - Last Update: 14 Feb 2020